42 reports

  • PAI PARTNERS TO ACQUIRE ELITECH FROM ERGON CAPITAL PARTNERS
  • Clinical Chemistry
  • France
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.

" WE ARE NOW EXPANDING THE MENU OF GENETIC TESTS OFFERED THROUGH BHL AND ARE DELIGHTED TO GAIN ACCESS TO JEAN' S BREADTH OF EXPERIENCE IN CLINICAL LABORATORY MANAGEMENT AND GENETIC TESTING. "

  • Clinical Chemistry
  • North America
  • Forecast
  • Market Size
  • Thermo Fisher Scientific, Inc.

It also provides food analysis test kits for the analysis of mycotoxins, antibiotics, hormones, genetically modified organisms, risk material, food allergens and microorganisms.

  • Clinical Chemistry
  • Brazil
  • South America
  • Abbott Laboratories, Inc.
  • Alere Inc.

THE TBG FACILITY COMMENCED HLA TYPING IN XIAMEN IN JULY 2016 AND CONTINUES TO BUILD ON ITS CORE TECHNOLOGIES OF IVD - & SHYRELATED NUC LEIC ACID TESTING KITS, TO INCLUDE INFECTIOUS DISEASES, ONCOLOGY, BLOOD SCREENING AND GENETIC TESTING.

  • Clinical Chemistry
  • Asia
  • Forecast
  • Market Size
  • Beckman Coulter, Inc.
  • 7.1.1.1 CLINICAL CHEMISTRY

From genetic tests that identify cancers, which guide us in the cancer treatment, to determine right antibiotics that fight an infection, diagnostics help in each step of medical care - prevention, protection, diagnosis and treatment and successful management of different health conditions.

  • Clinical Chemistry
  • World
  • Market Size
  • Elanco
  • Zoetis Inc.

Molecular diagnostics assess biological makeup at the genetic level.

  • Biomarker
  • Clinical Chemistry
  • Laboratory
  • United States
  • Market Size

Molecular diagnostics assess biological makeup at the genetic level.

  • Biomarker
  • Clinical Chemistry
  • Laboratory
  • United States
  • Market Size

Molecular diagnostics assess biological makeup at the genetic level.

  • Biomarker
  • Clinical Chemistry
  • Laboratory
  • United States
  • Market Size

Molecular diagnostics assess biological makeup at the genetic level.

  • Clinical Chemistry
  • Diagnostics
  • Laboratory
  • United States
  • Market Size

Molecular diagnostics assess biological makeup at the genetic level.

  • Clinical Chemistry
  • Diagnostics
  • Laboratory
  • United States
  • Market Size

Molecular diagnostics assess biological makeup at the genetic level.

  • Biomarker
  • Clinical Chemistry
  • Laboratory
  • United States
  • Market Size

Molecular diagnostics assess biological makeup at the genetic level.

  • Clinical Chemistry
  • Diagnostics
  • Laboratory
  • United States
  • Market Size

Molecular diagnostics assess biological makeup at the genetic level.

  • Clinical Chemistry
  • Diagnostics
  • Laboratory
  • United States
  • Market Size

Molecular diagnostics assess biological makeup at the genetic level.

  • Clinical Chemistry
  • Diagnostics
  • Laboratory
  • United States
  • Market Size

Molecular diagnostics assess biological makeup at the genetic level.

  • Biomarker
  • Clinical Chemistry
  • Laboratory
  • United States
  • Market Size

Molecular diagnostics assess biological makeup at the genetic level.

  • Biomarker
  • Clinical Chemistry
  • Laboratory
  • United States
  • Market Size
  • IN VITRO DIAGNOSTICS MARKET, CHINA, REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, CHINA, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021

TABLE ##: GENETIC TESTING MARKET, CHINA, REVENUE ($M), USD CONSTANT, FORECAST, 2014-2021 ##. ## GENETIC TESTING MARKET, CHINA, DISTRIBUTION SHARE BY REVENUE ($M), 2013-2014 TABLE ##: GENETIC TESTING MARKET, CHINA, DISTRIBUTION SHARE BY REVENUE ($M), USD CONSTANT, 2013-2014 &q

  • Clinical Chemistry
  • In Vitro Diagnostic Reagent
  • Asia
  • China
  • bioMerieux S.A.
  • IN VITRO DIAGNOSTICS MARKET, JAPAN, REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, JAPAN, CATEGORY CONTRIBUTION BY REVENUE ($M), 2014

TABLE ##: GENETIC TESTING MARKET, JAPAN, REVENUE ($M), USD CONSTANT, FORECAST, 2014-2021 ##. ## GENETIC TESTING MARKET, JAPAN, DISTRIBUTION SHARE BY REVENUE ($M), 2013-2014 TABLE ##: GENETIC TESTING MARKET, JAPAN, DISTRIBUTION SHARE BY REVENUE ($M), USD CONSTANT, 2013-2014 &q

  • Clinical Chemistry
  • Healthcare
  • Asia
  • Japan
  • Sosei Group Corporation
  • IN VITRO DIAGNOSTICS MARKET, BRAZIL, CATEGORY CONTRIBUTION BY REVENUE ($M), 2014
  • IN VITRO DIAGNOSTICS MARKET, BRAZIL, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021

TABLE ##: GENETIC TESTING MARKET, BRAZIL, REVENUE ($M), USD CONSTANT, FORECAST, 2014-2021 ##. ## GENETIC TESTING MARKET, BRAZIL, DISTRIBUTION SHARE BY REVENUE ($M), 2013-2014 TABLE ##: GENETIC TESTING MARKET, BRAZIL, DISTRIBUTION SHARE BY REVENUE ($M), USD CONSTANT, 2013-2014

  • Clinical Chemistry
  • In Vitro Diagnostics
  • Brazil
  • South America
  • bioMerieux S.A.
  • IN VITRO DIAGNOSTICS MARKET, JAPAN, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, INDIA, REVENUE ($M), USD CONSTANT, 2007-2021

TABLE ##: CLINICAL CHEMISTRY MARKET, INDIA, COMPANY SHARE BY REVENUE ($M), USD CONSTANT, 2014 ## Genetic Testing Market, India ##. ## GENETIC TESTING MARKET, INDIA, REVENUE MIX ($M), 2014 FIGURE ##: GENETIC TESTING MARKET, INDIA, REVENUE MIX ($M), 2014 ##. ## GENETIC TES

  • Clinical Chemistry
  • In Vitro Diagnostic Reagent
  • Asia
  • India
  • Tosoh Corporation
  • IN VITRO DIAGNOSTICS MARKET, ITALY, CATEGORY CONTRIBUTION BY REVENUE ($M), 2014
  • IN VITRO DIAGNOSTICS MARKET, ITALY, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021

Other Genetic Tests ##.

  • Clinical Chemistry
  • Medical Device
  • Europe
  • Italy
  • Curetis N.V.
  • IN VITRO DIAGNOSTICS MARKET, UNITED KINGDOM, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, UNITED KINGDOM, CATEGORY CONTRIBUTION BY REVENUE ($M), 2014

Genetic Testing chromosome alterations and other genetic tests have been tracked under this category.

  • Clinical Chemistry
  • Healthcare
  • Europe
  • United Kingdom
  • GE Healthcare Limited
  • IN VITRO DIAGNOSTICS MARKET, FRANCE, REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, FRANCE, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021

TABLE ##: GENETIC TESTING MARKET, FRANCE, REVENUE ($M), USD CONSTANT, FORECAST, 2014-2021 ##. ## GENETIC TESTING MARKET, FRANCE, DISTRIBUTION SHARE BY REVENUE ($M), 2013-2014 TABLE ##: GENETIC TESTING MARKET, FRANCE, DISTRIBUTION SHARE BY REVENUE ($M), USD CONSTANT, 2013-2014

  • Clinical Chemistry
  • Medical Device
  • Europe
  • France
  • bioMerieux S.A.
  • IN VITRO DIAGNOSTICS MARKET, GERMANY, REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, GERMANY, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021

Genetic Testing chromosome alterations and other genetic tests have been tracked under this category.

  • Clinical Chemistry
  • Healthcare
  • Europe
  • Germany
  • QIAGEN N.V.
  • IN VITRO DIAGNOSTICS MARKET, MEXICO, CATEGORY CONTRIBUTION BY REVENUE ($M), 2014
  • IN VITRO DIAGNOSTICS MARKET, MEXICO, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021

TABLE ##: GENETIC TESTING MARKET, MEXICO, REVENUE ($M), USD CONSTANT, FORECAST, 2014-2021 ##. ## GENETIC TESTING MARKET, MEXICO, DISTRIBUTION SHARE BY REVENUE ($M), 2013-2014 TABLE ##: GENETIC TESTING MARKET, MEXICO, DISTRIBUTION SHARE BY REVENUE ($M), USD CONSTANT, 2013-2014

  • Clinical Chemistry
  • Medical Device
  • Mexico
  • North America
  • bioMerieux S.A.
  • IN VITRO DIAGNOSTICS MARKET, AUSTRALIA, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, AUSTRALIA, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021

Genetic Testing chromosome alterations and other genetic tests have been tracked under this category.

  • Clinical Chemistry
  • Medical Device
  • Australia
  • Oceania
  • bioMerieux S.A.
  • IN VITRO DIAGNOSTICS MARKET, SPAIN, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, SPAIN, CATEGORY CONTRIBUTION BY REVENUE ($M), 2014

TABLE ##: GENETIC TESTING MARKET, SPAIN, REVENUE ($M), USD CONSTANT, FORECAST, 2014-2021 ##. ## GENETIC TESTING MARKET, SPAIN, DISTRIBUTION SHARE BY REVENUE ($M), 2013-2014 TABLE ##: GENETIC TESTING MARKET, SPAIN, DISTRIBUTION SHARE BY REVENUE ($M), USD CONSTANT, 2013-2014 &q

  • Clinical Chemistry
  • In Vitro Diagnostic Reagent
  • Europe
  • Spain
  • bioMerieux S.A.
  • IN VITRO DIAGNOSTICS MARKET, SOUTH KOREA, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, SOUTH KOREA, CATEGORY CONTRIBUTION BY REVENUE ($M), 2014

Hoffmann-La Roche Ltd. with ##. ##% and ##. ##% respectively. ## Genetic Testing Market, South Korea ##. ## GENETIC TESTING MARKET, SOUTH KOREA, REVENUE MIX ($M), 2014 FIGURE ##: GENETIC TESTING MARKET, SOUTH KOREA, REVENUE MIX ($M), 2014 ##. ## GENETIC TESTING MARKET, SOUTH

  • Clinical Chemistry
  • Medical Device
  • Asia
  • South Korea
  • bioMerieux S.A.
  • IN VITRO DIAGNOSTICS MARKET, RUSSIA, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, RUSSIA, CATEGORY CONTRIBUTION BY REVENUE ($M), 2014

TABLE ##: GENETIC TESTING MARKET, RUSSIA, REVENUE ($M), USD CONSTANT, FORECAST, 2014-2021 ##. ## GENETIC TESTING MARKET, RUSSIA, DISTRIBUTION SHARE BY REVENUE ($M), 2013-2014 TABLE ##: GENETIC TESTING MARKET, RUSSIA, DISTRIBUTION SHARE BY REVENUE ($M), USD CONSTANT, 2013-2014

  • Clinical Chemistry
  • In Vitro Diagnostic Reagent
  • Europe
  • Russian Federation
  • bioMerieux S.A.
  • IN VITRO DIAGNOSTICS MARKET, CANADA, CATEGORY COMPARISON BY REVENUE ($M), USD CONSTANT, 2007-2021
  • IN VITRO DIAGNOSTICS MARKET, CANADA, CATEGORY CONTRIBUTION BY REVENUE ($M), 2014

TABLE ##: GENETIC TESTING MARKET, CANADA, REVENUE ($M), USD CONSTANT, FORECAST, 2014-2021 ##. ## GENETIC TESTING MARKET, CANADA, DISTRIBUTION SHARE BY REVENUE ($M), 2013-2014 TABLE ##: GENETIC TESTING MARKET, CANADA, DISTRIBUTION SHARE BY REVENUE ($M), USD CONSTANT, 2013-2014

  • Clinical Chemistry
  • In Vitro Diagnostic Reagent
  • Canada
  • North America
  • Miraculins Inc.